Similar articles

• [Heparin-induced thrombopenia].

  Sardin B, Grouille D, Julia A, Demontoux MH, Colin D, Boulogne P, Ferrat PL, Feiss P. Sardin B, et al. Cah Anesthesiol. 1987 May-Jun;35(3):225-31. Cah Anesthesiol. 1987. PMID: 3304566 Review. French. No abstract available.
• [Prevention of immunoallergic thrombopenia induced by heparin].

  Grouille D, Sardin B, Colin D, Boulogne P. Grouille D, et al. Cah Anesthesiol. 1988 Jun-Jul;36(4):261-3. Cah Anesthesiol. 1988. PMID: 3167631 French. No abstract available.
• [Substitution of low-molecular-weight heparin for standard heparin in allergic thrombopenia].

  Pourrat E, Laurent G, Sie P, Lacheheb M, Bernies M, Desrez X. Pourrat E, et al. Presse Med. 1983 Sep 3;12(30):1875. Presse Med. 1983. PMID: 6225090 French. No abstract available.
• [Thrombopenia of immune origin during heparin therapy].

  Duthilleul P, De Coninck P, Plouvier B, Caridroit M. Duthilleul P, et al. Nouv Presse Med. 1982 May 22;11(24):1879-80. Nouv Presse Med. 1982. PMID: 7110941 French. No abstract available.
• The pathophysiology of heparin-induced thrombocytopenia: biological basis for treatment.

  Kelton JG. Kelton JG. Chest. 2005 Feb;127(2 Suppl):9S-20S. doi: 10.1378/chest.127.2_suppl.9S. Chest. 2005. PMID: 15706026 Review. No abstract available.